Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.083

€0.083

-78.840%
-
-78.840%
-
 
16.02.24 / Tradegate WKN: A14NKG / Name: Invitae / Stock / Biotechnology & Medical Research / Mid Cap / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Invitae

sharewise wants to provide you with the best news and tools for Invitae, so we directly link to the best financial data sources.

News

Is Invitae Stock a Buy Now?: https://g.foolcdn.com/editorial/images/762971/gettyimages-1072035598.jpg
Is Invitae Stock a Buy Now?

Invitae (NYSE: NVTA) has grown revenue over time, but the genetic testing specialist has failed to turn that into profit. Instead, the company burned through more and more cash, prompting it to

Invitae (NVTA) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Invitae (NVTA) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Invitae (NYSE: NVTA)Q3 2023 Earnings CallNov 08, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

3 Things About Invitae Every Smart Investor Knows: https://g.foolcdn.com/editorial/images/753343/researcher-loads-diagnostic-analyzer.jpg
3 Things About Invitae Every Smart Investor Knows

Genetic-testing company, Invitae (NYSE: NVTA), isn't as easy to understand as it might seem. After more than a year of pivoting and scaling down its operations, changing its leadership, and